I'm not gonna lie I personally can see why the market has reacted this way. While the results aren't bad they're not super amazing either. Yes it's great that the drug is safe but only 30% of patient showed a significant reduction and we just need to wait and see but that might not even be statistically significant.
Hopefully goes up from here because i'm at a loss as things stand
Ann: Positive interim analysis of DMX-200 phase II data-DXB.AX, page-91
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |